Advanced search
Publication Cover
Cancer Investigation Volume 12, 1994 - Issue 3
Submit an article Journal homepage
12
Views
20
CrossRef citations to date
0
Altmetric
Original Article

Economic Analysis in Phase III Clinical Cancer Trials

Charles L. Bennett Division of Health Services Research and Development, Durham Veterans Administration, Durham, North Carolina; Department of Medicine and the Center for Health Policy, Research, and Education, Duke University, Durham, North Carolina; Department of Accounting, University of Nebraska, Omaha, Nebraska; Division of Hematology/Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York; Schering-Plough Corporation, Kenilworth, New Jersey
,
Jack L. Armitage Division of Health Services Research and Development, Durham Veterans Administration, Durham, North Carolina; Department of Medicine and the Center for Health Policy, Research, and Education, Duke University, Durham, North Carolina; Department of Accounting, University of Nebraska, Omaha, Nebraska; Division of Hematology/Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York; Schering-Plough Corporation, Kenilworth, New Jersey
,
Deborah Buchner Division of Health Services Research and Development, Durham Veterans Administration, Durham, North Carolina; Department of Medicine and the Center for Health Policy, Research, and Education, Duke University, Durham, North Carolina; Department of Accounting, University of Nebraska, Omaha, Nebraska; Division of Hematology/Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York; Schering-Plough Corporation, Kenilworth, New Jersey
&
Subhash Gulati Division of Health Services Research and Development, Durham Veterans Administration, Durham, North Carolina; Department of Medicine and the Center for Health Policy, Research, and Education, Duke University, Durham, North Carolina; Department of Accounting, University of Nebraska, Omaha, Nebraska; Division of Hematology/Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York; Schering-Plough Corporation, Kenilworth, New Jersey
Pages 336-342 | Published online: 11 Jun 2009

References

  • Drummond MF, Davies L. Economic analysis alongside clinical trials: Revisiting the methodologies issues. Inter J Technol Assess Health Care 1991; 7: 561–563
  • Drummond MF, Stoddart GL. Economic analysis and clinical trial. Controlled Clin Trials 1984; 5: 115–128
  • Gulati SC, Bennett CL. Granulocyte-macrophage colony stimulating factor as adjunct therapy in relapsed Hodgkin disease. Ann Intern Med 1992; 116: 177–182
  • Jaakimainen I, Goodwin PJ, Pater J, Warde P, Murray N, Rapp E. Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in non-small cell lung cancer. j Clin Oncol 1990; 8: 1301–1309
  • Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia. Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia: A randomized, controlled clinical trial. N Engl J Med 1988; 319: 902–907
  • Weeks J, Tierney MR, Weinstein MC. Cost-effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia. N Engl J Med 1991; 325: 81–86
  • Kennedy BJ. Excessive test costs in clinical research protocols. J Cancer Educ 1991; 6: 93–97
  • Eisenberg JM, Glick H, Koffer H. Pharmacoeconomics: Economic evaluation of Pharmaceuticals. Pharmacoepidemiology, B Strom. Churchill Livingstone, New York 1989
  • Welch HG, Larson EB. Cost-effectiveness of bone marrow transplantation in acute nonlymphocytic leukemia. N Engl J Med 1989; 321: 807–812
  • Siminoff LA, Fetting JH. Factors affecting treatment decisions for a life-threatening illness: The case of medical treatment of breast cancer. Soc Sci Med 1991; 32: 813–818
  • Finkler SA. The distinction between cost and charges. Ann Intern Med 1982; 96: 102–109
  • Bennett CL, DeNeffe D. Does experience improve hospital performance in treating patients with AIDS. Health Policy 1993; 24: 35–43
  • Bennett CL, Gertler P, Guze PA, Garfinkle JB, Kanouse DE, Greenfield S. The relation between resource use and in-hospital mortality for patients with acquired immunodeficiency syndrome related Pneumocystis carinii pneumonia. Arch Intern Med 1990; 150: 1447–1452
  • Hannan EL, O'Donnell JF, Kilburn H, Bernard HR, Yazici A. Investigation of the relationship between volume and mortality for surgical procedures performed in New York State hospitals. JAMA 1989; 262: 503–510

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.